188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation: Research paper

British Journal of Haematology

Volumn 148, Issue 6, 2010, Pages 910-917

  Lauter, Anett ^a   Strumpf, Annette ^a   Platzbecker, Uwe ^a   Schetelig, Johannes ^a   Wermke, Martin ^a   Radke, Jörgen ^a   Kiani, Alexander ^a   Wunderlich, Gerd ^a   Thiede, Christian ^a   Ehninger, Gerhard ^a   Kotzerke, Jorg ^a   Bornhäuser, Martin ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Acute myeloid leukaemia; Allogeneic haematopoietic stem cell transplantation; Anti CD66 Rhenium; Conditioning therapy; Radioimmunotherapy

Indexed keywords

ALEMTUZUMAB; BUSULFAN; FLUDARABINE; RHENIUM 188; CD66 ANTIGENS; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; RADIOISOTOPE; RHENIUM; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHIMERA; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; T CELL DEPLETION; EPIDEMIOLOGY; ERYTHROCYTE TRANSFUSION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; METHODOLOGY; MIDDLE AGED; RECURRENT DISEASE; THROMBOCYTE TRANSFUSION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; EPIDEMIOLOGIC METHODS; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PLATELET TRANSFUSION; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RECURRENCE; RHENIUM; TRANSPLANTATION CONDITIONING;

EID: 77649205471     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08025.x     Document Type: Article

References (27)

1. Alyea, E.P., Kim, H.T., Ho, V., Cutler, C., DeAngelo, D.J., Stone, R., Ritz, J., Antin, J.H. Soiffer, R.J. (2006) Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biology of Blood and Marrow Transplantation, 12, 1047 1055.
2. Anderson, J.E., Appelbaum, F.R., Fisher, L.D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Doney, K., Martin, P.J., Sanders, J.E., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Hansen, J.A. Storb, R. (1993) Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood, 82, 677 681.
3. Bordessoule, D., Jones, M., Gatter, K.C. Mason, D.Y. (1993) Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. British Journal of Haematology, 83, 370 383.
4. Bornhauser, M., Thiede, C., Schuler, U., Platzbecker, U., Freiberg-Richter, J., Helwig, A., Plettig, R., Rollig, C., Naumann, R., Kroschinsky, F., Neubauer, A. Ehninger, G. (2000) Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin. Bone Marrow Transplantation, 26, 119 125.
5. Bornhauser, M., Thiede, C., Platzbecker, U., Jenke, A., Helwig, A., Plettig, R., Freiberg-Richter, J., Rollig, C., Geissler, G., Lutterbeck, K., Oelschlagel, U. Ehninger, G. (2001) Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clinical Cancer Research, 7, 2254 2262. (Pubitemid 32751622)
6. Buchmann, I., Bunjes, D., Kotzerke, J., Martin, H., Glatting, G., Seitz, U., Rattat, D., Buck, A., Dohner, H. Reske, S.N. (2002) Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities. Cancer Biotherapy & Radiopharmaceuticals, 17, 151 163.
7. Bunjes, D., Buchmann, I., Duncker, C., Seitz, U., Kotzerke, J., Wiesneth, M., Dohr, D., Stefanic, M., Buck, A., Harsdorf, S.V., Glatting, G., Grimminger, W., Karakas, T., Munzert, G., Dohner, H., Bergmann, L. Reske, S.N. (2001) Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study. Blood, 98, 565 572.
8. Cornelissen, J.J., van Putten, W.L., Verdonck, L.F., Theobald, M., Jacky, E., Daenen, S.M., van Marwijk Kooy, M., Wijermans, P., Schouten, H., Huijgens, P.C., van der Lelie, H., Fey, M., Ferrant, A., Maertens, J., Gratwohl, A. Lowenberg, B. (2007) Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood, 109, 3658 3666.
9. Kaplan, E. Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
10. Koenecke, C., Hofmann, M., Bolte, O., Gielow, P., Dammann, E., Stadler, M., Franzke, A., Boerner, A.R., Eder, M., Ganser, A., Knapp, W. Hertenstein, B. (2008) Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia. International Journal of Hematology, 87, 414 421.
11. Kottaridis, P.D., Milligan, D.W., Chopra, R., Chakraverty, R.K., Chakrabarti, S., Robinson, S., Peggs, K., Verfuerth, S., Pettengell, R., Marsh, J.C., Schey, S., Mahendra, P., Morgan, G.J., Hale, G., Waldmann, H., de Elvira, M.C., Williams, C.D., Devereux, S., Linch, D.C., Goldstone, A.H. Mackinnon, S. (2000) In vivo CAMPATH-1H prevents graft- versus -host disease following nonmyeloablative stem cell transplantation. Blood, 96, 2419 2425.
12. Kotzerke, J., Glatting, G., Seitz, U., Rentschler, M., Neumaier, B., Bunjes, D., Duncker, C., Dohr, D., Bergmann, L. Reske, S.N. (2000) Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs. Journal of Nuclear Medicine, 41, 531 537.
13. Lin, D.Y. (1997) Non-parametric inference for cumulative incidence functions in competing risks studies. Statistics in Medicine, 16, 901 910.
14. Matthews, D.C., Appelbaum, F.R., Eary, J.F., Fisher, D.R., Durack, L.D., Bush, S.A., Hui, T.E., Martin, P.J., Mitchell, D., Press, O.W., Badger, C.C., Storb, R., Nelp, W.B. Bernstein, I.D. (1995) Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood, 85, 1122 1131.
15. Mufti, G.J. Chen, T.L. (2008) Changing the treatment paradigm in myelodysplastic syndromes. Cancer Control, 15 (Suppl 14 28.
16. Nash, R.A., Pepe, M.S., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F.R., Bowden, R.A., Deeg, H.J. Doney, K. (1992) Acute graft- versus -host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood, 80, 1838 1845.
17. Noworolska, A., Harlozinska, A., Buchegger, F., Lawinska, B. Richter, R. (1989) Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects. Blut, 58, 69 73.
18. Pagel, J.M., Appelbaum, F.R., Eary, J.F., Rajendran, J., Fisher, D.R., Gooley, T., Ruffner, K., Nemecek, E., Sickle, E., Durack, L., Carreras, J., Horowitz, M.M., Press, O.W., Gopal, A.K., Martin, P.J., Bernstein, I.D. Matthews, D.C. (2006) 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Blood, 107, 328 336.
19. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. Thomas, E.D. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation, 15, 825 828.
20. Ringden, O., Remberger, M., Mattsson, J., Aschan, J., Carlens, S., Hagglund, H., Lonnqvist, B., Sparrelid, E. Ljungman, P. (1998) Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age. Bone Marrow Transplantation, 21, 43 49.
21. Ringhoffer, M., Blumstein, N., Neumaier, B., Glatting, G., von Harsdorf, S., Buchmann, I., Wiesneth, M., Kotzerke, J., Zenz, T., Buck, A.K., Schauwecker, P., Stilgenbauer, S., Dohner, H., Reske, S.N. Bunjes, D. (2005) 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study. British Journal of Haematology, 130, 604 613.
22. Rottinger, E.M., Bartkowiak, D., Bunjes, D., Wennauer, R. Dohr, D. (2003) Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy. Strahlentherapie und Onkologie, 179, 702 707.
23. Stabin, M.G. (1996) MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. Journal of Nuclear Medicine, 37, 538 546.
24. Sullivan, K.M., Agura, E., Anasetti, C., Appelbaum, F., Badger, C., Bearman, S., Erickson, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., Matthews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Schuening, F., Siadak, M., Storb, R. Whitherspoon, R.P. (1991) Chronic graft-versus -host disease and other late complications of bone marrow transplantation. Seminars in Hematology, 28, 250 259.
25. Thiede, C., Florek, M., Bornhauser, M., Ritter, M., Mohr, B., Brendel, C., Ehninger, G. Neubauer, A. (1999) Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplantation, 23, 1055 1060.
26. Valcarcel, D., Martino, R., Caballero, D., Martin, J., Ferra, C., Nieto, J.B., Sampol, A., Bernal, M.T., Pinana, J.L., Vazquez, L., Ribera, J.M., Besalduch, J., Moraleda, J.M., Carrera, D., Brunet, M.S., Perez-Simon, J.A. Sierra, J. (2008) Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus -host disease is the strongest factor improving survival. Journal of Clinical Oncology, 26, 577 584.
27. Zhang, M.M. Gopal, A.K. (2008) Radioimmunotherapy-based conditioning regimens for stem cell transplantation. Seminars in Hematology, 45, 118 125.